QQQ   359.61 (-2.90%)
AAPL   142.01 (-2.31%)
MSFT   285.02 (-3.11%)
FB   339.24 (-4.06%)
GOOGL   2,709.56 (-3.97%)
TSLA   778.00 (-1.69%)
AMZN   3,294.14 (-3.28%)
NVDA   207.06 (-4.40%)
BABA   150.39 (+0.14%)
NIO   35.13 (-4.46%)
CGC   14.20 (-3.47%)
GE   105.13 (-0.21%)
MU   73.40 (-2.37%)
AMD   102.41 (-5.32%)
T   27.21 (-0.69%)
F   14.38 (+1.55%)
ACB   6.78 (+6.10%)
DIS   174.34 (-2.20%)
PFE   42.87 (-1.61%)
BA   218.77 (-2.40%)
AMC   37.53 (-4.50%)
QQQ   359.61 (-2.90%)
AAPL   142.01 (-2.31%)
MSFT   285.02 (-3.11%)
FB   339.24 (-4.06%)
GOOGL   2,709.56 (-3.97%)
TSLA   778.00 (-1.69%)
AMZN   3,294.14 (-3.28%)
NVDA   207.06 (-4.40%)
BABA   150.39 (+0.14%)
NIO   35.13 (-4.46%)
CGC   14.20 (-3.47%)
GE   105.13 (-0.21%)
MU   73.40 (-2.37%)
AMD   102.41 (-5.32%)
T   27.21 (-0.69%)
F   14.38 (+1.55%)
ACB   6.78 (+6.10%)
DIS   174.34 (-2.20%)
PFE   42.87 (-1.61%)
BA   218.77 (-2.40%)
AMC   37.53 (-4.50%)
QQQ   359.61 (-2.90%)
AAPL   142.01 (-2.31%)
MSFT   285.02 (-3.11%)
FB   339.24 (-4.06%)
GOOGL   2,709.56 (-3.97%)
TSLA   778.00 (-1.69%)
AMZN   3,294.14 (-3.28%)
NVDA   207.06 (-4.40%)
BABA   150.39 (+0.14%)
NIO   35.13 (-4.46%)
CGC   14.20 (-3.47%)
GE   105.13 (-0.21%)
MU   73.40 (-2.37%)
AMD   102.41 (-5.32%)
T   27.21 (-0.69%)
F   14.38 (+1.55%)
ACB   6.78 (+6.10%)
DIS   174.34 (-2.20%)
PFE   42.87 (-1.61%)
BA   218.77 (-2.40%)
AMC   37.53 (-4.50%)
QQQ   359.61 (-2.90%)
AAPL   142.01 (-2.31%)
MSFT   285.02 (-3.11%)
FB   339.24 (-4.06%)
GOOGL   2,709.56 (-3.97%)
TSLA   778.00 (-1.69%)
AMZN   3,294.14 (-3.28%)
NVDA   207.06 (-4.40%)
BABA   150.39 (+0.14%)
NIO   35.13 (-4.46%)
CGC   14.20 (-3.47%)
GE   105.13 (-0.21%)
MU   73.40 (-2.37%)
AMD   102.41 (-5.32%)
T   27.21 (-0.69%)
F   14.38 (+1.55%)
ACB   6.78 (+6.10%)
DIS   174.34 (-2.20%)
PFE   42.87 (-1.61%)
BA   218.77 (-2.40%)
AMC   37.53 (-4.50%)
NASDAQ:VVOS

Vivos Therapeutics Short Interest Ratio and Short Volume

$4.37
+0.01 (+0.23 %)
(As of 09/28/2021 11:43 AM ET)
Add
Compare
Today's Range
$4.30
$4.45
50-Day Range
$2.71
$5.90
52-Week Range
$2.61
$14.41
Volume6,707 shs
Average Volume1.29 million shs
Market Capitalization$99.69 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Vivos Therapeutics (NASDAQ:VVOS) Short Interest Data

Current Short Volume652,700 shares
Previous Short Volume43,800 shares
Change Vs. Previous Month+1,390.18%
Dollar Volume Sold Short$3.43 million
Short Interest Ratio / Days to Cover0.2
Last Record DateAugust, 31 2021
Outstanding Shares22,812,000 shares
Float Size13,710,000 shares
Short Percent of Float4.76%
Today's Trading Volume6,707 shares
Average Trading Volume1,292,827 shares
Today's Volume Vs. Average-99.48%

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Vivos Therapeutics ?

Sign up to receive the latest short interest report for Vivos Therapeutics and its competitors with MarketBeat's FREE newsletter.

Vivos Therapeutics (NASDAQ:VVOS) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/2021652,700 shares $3.43 million +1,390.2%4.8%0.2 $5.26
8/13/202143,800 shares $143,226.00 -25.8%0.3%0 $3.27
7/30/202159,000 shares $178,180.00 -50.7%0.4%0.2 $3.02
7/15/2021119,700 shares $514,710.00 +193.4%0.9%0.4 $4.30
6/30/202140,800 shares $201,960.00 -17.7%0.3%0.1 $4.95
6/15/202149,600 shares $288,176.00 -22.0%0.4%0.3 $5.81
5/28/202163,600 shares $342,168.00 +1.0%0.5%0.3 $5.38
5/14/202163,000 shares $372,960.00 +90.3%0.5%0.4 $5.92
4/30/202133,100 shares $223,425.00 -45.7%0.3%0.2 $6.75
4/15/202160,900 shares $542,010.00 +45.4%0.6%0.3 $8.90
3/31/202141,900 shares $283,663.00 +165.2%0.4%0.2 $6.77
3/15/202115,800 shares $117,552.00 -31.9%0.2%0.1 $7.44
2/26/202123,200 shares $174,928.00 -33.9%0.2%0 $7.54
2/12/202135,100 shares $245,349.00 +317.9%0.3%0.1 $6.99
1/29/20218,400 shares $56,658.00 -88.0%0.1%0 $6.75
1/15/202170,100 shares $560,099.00 No Change0.6%0.1 $7.99

Vivos Therapeutics (NASDAQ:VVOS) Short Interest FAQ

speech bubbles
speech bubbles











Vivos Therapeutics (NASDAQ:VVOS) Short Interest Frequently Asked Questions

What is Vivos Therapeutics' current short interest?

Short interest is the volume of Vivos Therapeutics shares that have been sold short but have not yet been covered or closed out. As of August 31st, traders have sold 652,700 shares of VVOS short. 4.76% of Vivos Therapeutics' shares are currently sold short. Learn More on Vivos Therapeutics' current short interest.

What is a good short interest percentage for Vivos Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.76% of Vivos Therapeutics' floating shares are currently sold short.

Is Vivos Therapeutics' short interest increasing or decreasing?

Vivos Therapeutics saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 652,700 shares, an increase of 1,390.2% from the previous total of 43,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Vivos Therapeutics' float size?

Vivos Therapeutics currently has issued a total of 22,812,000 shares. Some of Vivos Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vivos Therapeutics currently has a public float of 13,710,000 shares.

How does Vivos Therapeutics' short interest compare to its competitors?

4.76% of Vivos Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Vivos Therapeutics: Molecular Templates, Inc. (3.18%), ProQR Therapeutics (3.95%), Silverback Therapeutics, Inc. (19.81%), ClearPoint Neuro, Inc. (4.97%), Outlook Therapeutics, Inc. (6.40%), Retractable Technologies, Inc. (19.45%), Spectrum Pharmaceuticals, Inc. (0.00%), NeuroPace, Inc. (9.35%), Aeglea BioTherapeutics, Inc. (2.50%), and UpHealth, Inc. (2.93%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Square, Inc. ($9.81 billion), S&P Global Inc. ($7.52 billion), Advanced Micro Devices, Inc. ($7.18 billion), Charter Communications, Inc. ($6.21 billion), Wayfair Inc. ($4.60 billion), Zoom Video Communications, Inc. ($3.23 billion), Uber Technologies, Inc. ($3.11 billion), Palo Alto Networks, Inc. ($2.74 billion), Teladoc Health, Inc. ($2.52 billion), and Etsy, Inc. ($2.16 billion). View all of the most shorted stocks.

What does it mean to sell short Vivos Therapeutics stock?

Short selling VVOS is an investing strategy that aims to generate trading profit from Vivos Therapeutics as its price is falling. Vivos Therapeutics' stock is trading up $0.01 today. To short Vivos Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Vivos Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Vivos Therapeutics?

A short squeeze for Vivos Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VVOS, which in turn drives the price of the stock up even further.

How often is Vivos Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VVOS, twice per month. The most recent reporting period available is August, 31 2021.



This page was last updated on 9/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.